Neurogene Inc (NGNE)
36.42
+1.60
(+4.60%)
USD |
NASDAQ |
Jun 28, 16:00
36.40
-0.02
(-0.05%)
After-Hours: 20:00
Neurogene Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Taysha Gene Therapies Inc | 0.7523 |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.5332 |
IGC Pharma Inc | 0.0187 |
NovaBay Pharmaceuticals Inc | 6.294 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 195.35M |
Total Liabilities (Quarterly) | 24.57M |
Shareholders Equity (Quarterly) | 170.78M |